Showing results (191-200 of 324) with videos related to

Sort By:
Pageof 33
Gastrointestinal Cancer Research : GCR|May 11, 2012
ACR Appropriateness Criteria®-Recurrent Rectal CancerAndre A Konski, W Warren Suh, Joseph M Herman, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 16, 2011
Genetic manipulation of lignin reduces recalcitrance and improves ethanol production from switchgrassChunxiang Fu, Jonathan R Mielenz, Xirong Xiao, et al.
Proteomics|June 8, 2006
A phyloproteomic characterization of in vitro autophosphorylation in calcium-dependent protein kinasesAdrian D Hegeman, Miguel Rodriguez, Byung Woo Han, et al.
BMC Microbiology|January 7, 2021
The type VI secretion system of Xanthomonas phaseoli pv. manihotis is involved in virulence and in vitro motilityNathaly Andrea Montenegro Benavides, Alejandro Alvarez B, Mario L Arrieta-Ortiz, et al.
Therapeutic Innovation & Regulatory Science|August 16, 2022
Comparison of Good Clinical Practice Inspection Processes for Marketing Applications Between the United States Food and Drug Administration and the European Medicines AgencyKassa Ayalew, Yang-Min Ning, Michelle J Foringer, et al.
Medrxiv : the Preprint Server for Health Sciences|February 14, 2024
Transient peripheral blood transcriptomic response to ketamine treatment in children with ADNP syndromeAriela S Buxbaum Grice, Laura Sloofman, Tess Levy, et al.
Emerging Infectious Diseases|September 12, 2003
Legionnaires' disease outbreak in Murcia, SpainAnna García-Fulgueiras, Carmen Navarro, Daniel Fenoll, et al.
Viruses|December 23, 2023
Maternal COVID-19 Serological Changes-Comparison between Seroconversion Rate in First and Third Trimesters of Pregnancy and Subsequent Obstetric Complications: A Cohort StudyMaria N Rayo, Adriana Aquise, Irene Fernandez-Buhigas, et al.
Translational Psychiatry|July 25, 2024
Transient peripheral blood transcriptomic response to ketamine treatment in children with ADNP syndromeAriela S Buxbaum Grice, Laura Sloofman, Tess Levy, et al.
Neurology. Clinical Practice|August 26, 2024
An Interprofessional Team for Disease-Modifying Therapy in Alzheimer Disease ImplementationKatherine W Turk, Mark D Knobel, Alexandra Nothern, et al.
Pageof 33